Leukoaraiosis: Epidemiology, Imaging, Risk Factors, and Management of Age-Related Cerebral White Matter Hyperintensities

키워드

참고문헌 (399)

1. Hachinski VC, "Leuko-araiosis", Arch Neurol, 44, pp.21~23 (1987)
2. O’Sullivan M, "Leukoaraiosis", Pract Neurol, 8, pp.26~38 (2008)
3. Hachinski VC, "Leuko-araiosis : an ancient term for a new problem", Can J Neurol Sci, 13(4 Suppl), pp.533~534 (1986)
4. Longstreth WT Jr, "Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The cardiovascular health study", Stroke, 27, pp.1274~1282 (1996)
5. Lin Q, "Incidence and risk factors of leukoaraiosis from 4683 hospitalized patients: a cross-sectional study", Medicine (Baltimore), 96, pp.e7682~ (2017)
6. Wen W, "White matter hyperintensities in the forties : their prevalence and topography in an epidemiological sample aged 44-48", Hum Brain Mapp, 30, pp.1155~1167 (2009)
7. Ylikoski A, "White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home", Stroke, 26, pp.1171~1177 (1995)
8. Dufouil C, "Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history", Stroke, 40, pp.2219~2221 (2009)
9. van den Heuvel DM, "Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population", J Neurol Neurosurg Psychiatry, 77, pp.149~153 (2006)
10. Zheng JJ, "Impact of white matter lesions on physical functioning and fall risk in older people : a systematic review", Stroke, 42, pp.2086~2090 (2011)
11. Moon SY, "Prospective associations between white matter hyperintensities and lower extremity function", Neurology, 90, pp.e1291~e1297 (2018)
12. Lee Y, "Areas of white matter hyperintensities and motor symptoms of Parkinson disease", Neurology, 95, pp.e291~e298 (2020)
13. Clancy U, "Neuropsychiatric symptoms associated with cerebral small vessel disease : a systematic review and metaanalysis", Lancet Psychiatry, 8, pp.225~236 (2021)
14. Tosto G, "Predicting aggressive decline in mild cognitive impairment : the importance of white matter hyperintensities", JAMA Neurol, 71, pp.872~877 (2014)
15. Kloppenborg RP, "Presence and progression of white matter hyperintensities and cognition : a meta-analysis", Neurology, 82, pp.2127~2138 (2014)
16. Prins ND, "White matter hyperintensities, cognitive impairment and dementia : an update", Nat Rev Neurol, 11, pp.157~165 (2015)
17. Hu HY, "White matter hyperintensities and risks of cognitive impairment and dementia : a systematic review and meta-analysis of 36 prospective studies", Neurosci Biobehav Rev, 120, pp.16~27 (2021)
18. Whitman GT, "A prospective study of cerebral white matter abnormalities in older people with gait dysfunction", Neurology, 57, pp.990~994 (2001)
19. Srikanth V, "Cerebral white matter lesions, gait, and the risk of incident falls : a prospective population-based study", Stroke, 40, pp.175~180 (2009)
20. Su C, "Association of cerebral small vessel disease with gait and balance disorders", Front Aging Neurosci, 14, pp.834496~ (2022)
21. Debette S, "The clinical importance of white matter hyperintensities on brain magnetic resonance imaging : systematic review and meta-analysis", BMJ, 341, pp.c3666~ (2010)
22. Ryu WS, "Stroke outcomes are worse with larger leukoaraiosis volumes", Brain, 140, pp.158~170 (2017)
23. Georgakis MK, "WMH and long-term outcomes in ischemic stroke : a systematic review and meta-analysis", Neurology, 92, pp.e1298~e1308 (2019)
24. Imaizumi T, "The severities of white matter lesions possibly influence the recurrences of several stroke types", J Stroke Cerebrovasc Dis, 23, pp.1897~1902 (2014)
25. Rensma SP, "Cerebral small vessel disease and risk of incident stroke, dementia and depression, and all-cause mortality : a systematic review and meta-analysis", Neurosci Biobehav Rev, 90, pp.164~173 (2018)
26. Ghaznawi R, "Association of white matter hyperintensity markers on MRI and long-term risk of mortality and ischemic stroke : the SMART-MR study", Neurology, 96, pp.e2172~e2183 (2021)
27. Godin O, "White matter lesions as a predictor of depression in the elderly : the 3C-Dijon study", Biol Psychiatry, 63, pp.663~669 (2008)
28. Herrmann LL, "White matter hyperintensities in late life depression : a systematic review", J Neurol Neurosurg Psychiatry, 79, pp.619~624 (2008)
29. Wang L, "White matter lesions and depression : a systematic review and meta-analysis", J Psychiatr Res, 56, pp.56~64 (2014)
30. Fang Y, "Cerebral small-vessel disease and risk of incidence of depression : a meta-analysis of longitudinal cohort studies", J Am Heart Assoc, 9, pp.e016512~ (2020)
31. Launer LJ, "Regional variability in the prevalence of cerebral white matter lesions : an MRI study in 9 European countries(CASCADE)", Neuroepidemiology, 26, pp.23~29 (2006)
32. Mok V, "Race-ethnicity and cerebral small vessel disease--comparison between Chinese and White populations", Int J Stroke, 9(Suppl A100), pp.36~42 (2014)
33. de Leeuw FE, "Prevalence of cerebral white matter lesions in elderly people : a population based magnetic resonance imaging study. The Rotterdam scan study", J Neurol Neurosurg Psychiatry, 70, pp.9~14 (2001)
34. Wen W, "The topography of white matter hyperintensities on brain MRI in healthy 60-to 64-year-old individuals", Neuroimage, 22, pp.144~154 (2004)
35. Liao D, "The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors : the ARIC study", Neuroepidemiology, 16, pp.149~162 (1997)
36. Lam BYK, "High burden of cerebral white matter lesion in 9 Asian cities", Sci Rep, 11, pp.11587~ (2021)
37. Zhang S, "Investigation of the risk factors for leukoaraiosis(LA)", Asia Pac J Public Health, 25(4 Suppl), pp.64S~71S (2013)
38. Han F, "Prevalence and risk factors of cerebral small vessel disease in a Chinese population-based sample", J Stroke, 20, pp.239~246 (2018)
39. Jin H, "Prevalence and risk factors of white matter lesions in Tibetan patients without acute stroke", Stroke, 51, pp.149~153 (2020)
40. Verny M, "Leuko-araiosis", Dev Neurosci, 13, pp.245~250 (1991)
41. Wahlund LO, "A new rating scale for age-related white matter changes applicable to MRI and CT", Stroke, 32, pp.1318~1322 (2001)
42. Xiong YY, "Age-related white matter changes", J Aging Res, 2011, pp.617927~ (2011)
43. Fazekas F, "CT and MRI rating of white matter lesions", Cerebrovasc Dis, 13(Suppl 2), pp.31~36 (2002)
44. Kates R, "Fluid-attenuated inversion recovery(FLAIR) : clinical prospectus of current and future applications", Top Magn Reson Imaging, 8, pp.389~396 (1996)
45. Caligiuri ME, "Automatic detection of white matter hyperintensities in healthy aging and pathology using magnetic resonance imaging : a review", Neuroinformatics, 13, pp.261~276 (2015)
46. Tomura N, "Comparison of multishot echo-planar fluid-attenuated inversion-recovery imaging with fast spin-echo fluid-attenuated inversion-recovery and T2-weighted imaging in depiction of white matter lesions", J Comput Assist Tomogr, 26, pp.810~814 (2002)
47. Piguet O, "Comparing white matter lesions on T2 and FLAIR MRI in the Sydney older persons study", Eur J Neurol, 12, pp.399~402 (2005)
48. Barkhof F, "Imaging of white matter lesions", Cerebrovasc Dis, 13(Suppl 2), pp.21~30 (2002)
49. Grueter BE, "Age-related cerebral white matter disease(leukoaraiosis) : a review", Postgrad Med J, 88, pp.79~87 (2012)
50. Taylor WD, "Diffusion tensor imaging : background, potential, and utility in psychiatric research", Biol Psychiatry, 55, pp.201~207 (2004)
51. Assaf Y, "Diffusion tensor imaging(DTI)-based white matter mapping in brain research : a review", J Mol Neurosci, 34, pp.51~61 (2008)
52. Jones DK, "Characterization of white matter damage in ischemic leukoaraiosis with diffusion tensor MRI", Stroke, 30, pp.393~397 (1999)
53. Haacke EM, "Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain", J Magn Reson Imaging, 26, pp.256~264 (2007)
54. Kraft E, "T2*-weighted MRI differentiates multiple system atrophy from Parkinson’s disease", Neurology, 59, pp.1265~1267 (2002)
55. Yates PA, "Cerebral microbleeds : a review of clinical, genetic, and neuroimaging associations", Front Neurol, 4, pp.205~ (2014)
56. Huang WQ, "Susceptibility weighted imaging(SWI)recommended as a regular magnetic resonance diagnosis for vascular dementia to identify independent idiopathic normal pressure hydrocephalus before ventriculo-peritoneal(V-P)shunt treatment : a case study", Front Neurol, 10, pp.262~ (2019)
57. Fazekas F, "MR signal abnormalities at 1. 5 T in Alzheimer’s dementia and normal aging", AJR Am J Roentgenol, 149, pp.351~356 (1987)
58. Schmidt R, "Heterogeneity in age-related white matter changes", Acta Neuropathol, 122, pp.171~185 (2011)
59. Kim KW, "Classification of white matter lesions on magnetic resonance imaging in elderly persons", Biol Psychiatry, 64, pp.273~280 (2008)
60. Payne ME, "Development of a semi-automated method for quantification of MRI gray and white matter lesions in geriatric subjects", Psychiatry Res, 115, pp.63~77 (2002)
61. Scheltens P, "White matter changes on CT and MRI : an overview of visual rating scales", Eur Neurol, 39, pp.80~89 (1998)
62. Mäntylä R, "Variable agreement between visual rating scales for white matter hyperintensities on MRI. Comparison of 13 rating scales in a poststroke cohort", Stroke, 28, pp.1614~1623 (1997)
63. Kapeller P, "Visual rating of age-related white matter changes on magnetic resonance imaging : scale comparison, interrater agreement, and correlations with quantitative measurements", Stroke, 34, pp.441~445 (2003)
64. Admiraal-Behloul F, "Fully automatic segmentation of white matter hyperintensities in MR images of the elderly", Neuroimage, 28, pp.607~617 (2005)
65. Scheltens P, "A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging", J Neurol Sci, 114, pp.7~12 (1993)
66. Andere A, "Volumetric white matter hyperintensity ranges correspond to Fazekas scores on brain MRI", J Stroke Cerebrovasc Dis, 31, pp.106333~ (2022)
67. Lin Q, "Genetic associations of leukoaraiosis indicate pathophysiological mechanisms in white matter lesions etiology", Rev Neurosci, 26, pp.343~358 (2015)
68. Huang WQ, "DNA methylation profiling reveals the change of inflammationassociated ZC3H12D in leukoaraiosis", Front Aging Neurosci, 10, pp.143~ (2018)
69. Griffanti L, "Classification and characterization of periventricular and deep white matter hyperintensities on MRI : a study in older adults", Neuroimage, 170, pp.174~181 (2018)
70. de Groot JC, "Cerebral white matter lesions and depressive symptoms in elderly adults", Arch Gen Psychiatry, 57, pp.1071~1076 (2000)
71. Krishnan MS, "Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS study", Int J Geriatr Psychiatry, 21, pp.983~989 (2006)
72. Fazekas F, "Pathologic correlates of incidental MRI white matter signal hyperintensities", Neurology, 43, pp.1683~1689 (1993)
73. Prins ND, "Cerebral white matter lesions and the risk of dementia", Arch Neurol, 61, pp.1531~1534 (2004)
74. de Groot JC, "Cerebral white matter lesions and cognitive function : the Rotterdam scan study", Ann Neurol, 47, pp.145~151 (2000)
75. De Groot JC, "Periventricular cerebral white matter lesions predict rate of cognitive decline", Ann Neurol, 52, pp.335~341 (2002)
76. Sze G, "Foci of MRI signal(pseudo lesions)anterior to the frontal horns : histologic correlations of a normal finding", AJR Am J Roentgenol, 147, pp.331~337 (1986)
77. Fazekas F, "Pathophysiologic mechanisms in the development of age-related white matter changes of the brain", Dement Geriatr Cogn Disord, 9(Suppl 1), pp.2~5 (1998)
78. Thomas AJ, "A neuropathological study of periventricular white matter hyperintensities in major depression", J Affect Disord, 76, pp.49~54 (2003)
79. van Swieten JC, "Periventricular lesions in the white matter on magnetic resonance imaging in the elderly : a morphometric correlation with arteriolosclerosis and dilated perivascular spaces", Brain, 114(Pt 2), pp.761~774 (1991)
80. Wu X, "Pathogeneses and imaging features of cerebral white matter lesions of vascular origins", Aging Dis, 12, pp.2031~2051 (2021)
81. Mayer PL, "The controversy of the periventricular white matter circulation : a review of the anatomic literature", AJNR Am J Neuroradiol, 12, pp.223~228 (1991)
82. Moody DM, "Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency : an anatomic study", AJNR Am J Neuroradiol, 11, pp.431~439 (1990)
83. Beyer JL, "Hyperintense MRI lesions in bipolar disorder : a meta-analysis and review", Int Rev Psychiatry, 21, pp.394~409 (2009)
84. ten Dam VH, "Decline in total cerebral blood flow is linked with increase in periventricular but not deep white matter hyperintensities", Radiology, 243, pp.198~203 (2007)
85. Stewart PA, "A quantitative analysis of blood-brain barrier ultrastructure in the aging human", Microvasc Res, 33, pp.270~282 (1987)
86. Pantoni L, "Pathogenesis of leukoaraiosis : a review", Stroke, 28, pp.652~659 (1997)
87. Pantoni L, "Pathophysiology of age-related cerebral white matter changes", Cerebrovasc Dis, 13(Suppl 2), pp.7~10 (2002)
88. Jung KH, "Heterogeneity of cerebral white matter lesions and clinical correlates in older adults", Stroke, 52, pp.620~630 (2021)
89. Schmidt R, "MRI white matter hyperintensities : three-year follow-up of the Austrian stroke prevention study", Neurology, 53, pp.132~139 (1999)
90. Schmidt R, "Progression of cerebral white matter lesions : 6-year results of the Austrian stroke prevention study", Lancet, 361, pp.2046~2048 (2003)
91. Longstreth WT Jr, "Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly : the cardiovascular health study", Stroke, 36, pp.56~61 (2005)
92. Taylor WD, "Serial MR imaging of volumes of hyperintense white matter lesions in elderly patients : correlation with vascular risk factors", AJR Am J Roentgenol, 181, pp.571~576 (2003)
93. Masana Y, "Emergence and progress of white matter lesion in brain check-up", Acta Neurol Scand, 107, pp.187~194 (2003)
94. van Dijk EJ, "Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences : Rotterdam scan study", Stroke, 39, pp.2712~2719 (2008)
95. Sachdev P, "Progression of white matter hyperintensities in elderly individuals over 3 years", Neurology, 68, pp.214~222 (2007)
96. Gyanwali B, "Risk factors for and clinical relevance of incident and progression of cerebral small vessel disease markers in an Asian memory clinic population", J Alzheimers Dis, 67, pp.1209~1219 (2019)
97. Sachdev P, "White matter hyperintensities in mid-adult life", Curr Opin Psychiatry, 21, pp.268~274 (2008)
98. van den Heuvel DM, "Different progression rates for deep white matter hyperintensities in elderly men and women", Neurology, 63, pp.1699~1701 (2004)
99. Liao D, "Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control : the ARIC study", Stroke, 27, pp.2262~2270 (1996)
100. de Leeuw FE, "A follow-up study of blood pressure and cerebral white matter lesions", Ann Neurol, 46, pp.827~833 (1999)
101. de Leeuw FE, "Hypertension and cerebral white matter lesions in a prospective cohort study", Brain, 125(Pt 4), pp.765~772 (2002)
102. van Dijk EJ, "The association between blood pressure, hypertension, and cerebral white matter lesions : cardiovascular determinants of dementia study", Hypertension, 44, pp.625~630 (2004)
103. Zhao Y, "Volume of white matter hyperintensities increases with blood pressure in patients with hypertension", J Int Med Res, 47, pp.3681~3689 (2019)
104. Basile AM, "Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes : the LADIS(leukoaraiosis and disability in the elderly)study", Cerebrovasc Dis, 21, pp.315~322 (2006)
105. Vuorinen M, "Changes in vascular risk factors from midlife to late life and white matter lesions : a 20-year follow-up study", Dement Geriatr Cogn Disord, 31, pp.119~125 (2011)
106. Habes M, "White matter hyperintensities and imaging patterns of brain ageing in the general population", Brain, 139(Pt 4), pp.1164~1179 (2016)
107. Guo X, "Blood pressure components and changes in relation to white matter lesions : a 32-year prospective population study", Hypertension, 54, pp.57~62 (2009)
108. Lane CA, "Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort(Insight 46) : an epidemiological study", Lancet Neurol, 18, pp.942~952 (2019)
109. Wartolowska KA, "Midlife blood pressure is associated with the severity of white matter hyperintensities : analysis of the UK Biobank cohort study", Eur Heart J, 42, pp.750~757 (2021)
110. Sargurupremraj M, "Cerebral small vessel disease genomics and its implications across the lifespan", Nat Commun, 11, pp.6285~ (2020)
111. Wilkinson I, "Consistency of associations of systolic and diastolic blood pressure with white matter hyperintensities : a meta-analysis", Int J Stroke, 17, pp.291~298 (2022)
112. Marcus J, "Baseline and longitudinal increases in diastolic blood pressure are associated with greater white matter hyperintensity volume : the northern Manhattan study", Stroke, 42, pp.2639~2641 (2011)
113. Shokouhi M, "Differential associations of diastolic and systolic pressures with cerebral measures in older individuals with mild cognitive impairment", Am J Hypertens, 31, pp.1268~1277 (2018)
114. Sudre CH, "Cardiovascular risk factors and white matter hyperintensities : difference in susceptibility in South Asians compared with Europeans", J Am Heart Assoc, 7, pp.e010533~ (2018)
115. Caunca MR, "Diastolic blood pressure is associated with regional white matter lesion load : the northern Manhattan study", Stroke, 51, pp.372~378 (2020)
116. Verhaaren BF, "High blood pressure and cerebral white matter lesion progression in the general population", Hypertension, 61, pp.1354~1359 (2013)
117. Dufouil C, "Longitudinal study of blood pressure and white matter hyperintensities : the EVA MRI cohort", Neurology, 56, pp.921~926 (2001)
118. Pantoni L, "Cerebral small vessel disease : from pathogenesis and clinical characteristics to therapeutic challenges", Lancet Neurol, 9, pp.689~701 (2010)
119. Sierra C, "Essential hypertension, cerebral white matter pathology and ischemic stroke", Curr Med Chem, 21, pp.2156~2164 (2014)
120. Dufouil C, "Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke : the PROGRESS(perindopril protection against recurrent stroke study)magnetic resonance imaging substudy", Circulation, 112, pp.1644~1650 (2005)
121. Firbank MJ, "Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure", J Neurol, 254, pp.713~721 (2007)
122. van Middelaar T, "Effect of antihypertensive medication on cerebral small vessel disease : a systematic review and metaanalysis", Stroke, 49, pp.1531~1533 (2018)
123. Kjeldsen SE, "Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain : the SPRINT memory and cognition in decreased hypertension(SPRINT MIND)study", Blood Press, 27, pp.247~248 (2018)
124. SPRINT MIND Investigators for the SPRINT Research Group, "Association of intensive vs standard blood pressure control with cerebral white matter lesions", JAMA, 322, pp.524~534 (2019)
125. Cox SR, "Associations between vascular risk factors and brain MRI indices in UK Biobank", Eur Heart J, 40, pp.2290~2300 (2019)
126. Veldink JH, "Progression of cerebral white matter hyperintensities on MRI is related to diastolic blood pressure", Neurology, 51, pp.319~320 (1998)
127. Zhang D, "Age and diastolic blood pressure play an important role in the progression of white matter lesions : a meta-analysis", Eur Neurol, 83, pp.351~359 (2020)
128. Pantoni L, "The significance of cerebral white matter abnormalities 100 years after Binswanger’s report. A review", Stroke, 26, pp.1293~1301 (1995)
129. Topakian R, "Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis", J Neurol Neurosurg Psychiatry, 81, pp.192~197 (2010)
130. Oishi E, "Day-to-day blood pressure variability and risk of dementia in a general Japanese elderly population : the Hisayama study", Circulation, 136, pp.516~525 (2017)
131. Stevens SL, "Blood pressure variability and cardiovascular disease : systematic review and meta-analysis", BMJ, 354, pp.i4098~ (2016)
132. Alpérovitch A, "Blood pressure variability and risk of dementia in an elderly cohort, the three-city study", Alzheimers Dement, 10(5 Suppl), pp.S330~S337 (2014)
133. Gunstad J, "Blood pressure variability and white matter hyperintensities in older adults with cardiovascular disease", Blood Press, 14, pp.353~358 (2005)
134. Brickman AM, "Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort", Arch Neurol, 67, pp.564~569 (2010)
135. Liu Z, "Excessive variability in systolic blood pressure that is self-measured at home exacerbates the progression of brain white matter lesions and cognitive impairment in the oldest old", Hypertens Res, 39, pp.245~253 (2016)
136. Filomena J, "Short-term blood pressure variability relates to the presence of subclinical brain small vessel disease in primary hypertension", Hypertension, 66, pp.634~640 (2015)
137. Yang S, "Twenty-fourhour ambulatory blood pressure variability is associated with total magnetic resonance imaging burden of cerebral smallvessel disease", Clin Interv Aging, 13, pp.1419~1427 (2018)
138. Chen X, "Association of blood pressure variability and intima-media thickness with white matter hyperintensities in hypertensive patients", Front Aging Neurosci, 11, pp.192~ (2019)
139. van Middelaar T, "Visit-to-visit blood pressure variability and progression of white matter hyperintensities among older people with hypertension", J Am Med Dir Assoc, 20, pp.1175~1177 (2019)
140. Shen J, "Association between twentyfour-hour ambulatory blood pressure variability and cerebral small vessel disease burden in acute ischemic stroke", Behav Neurol, 2022, pp.3769577~ (2022)
141. Zhang B, "Day to day blood pressure variability associated with cerebral arterial dilation and white matter hyperintensity", Hypertension, 79, pp.1455~1465 (2022)
142. Tully PJ, "Association between blood pressure variability and cerebral small-vessel disease : a systematic review and meta-analysis", J Am Heart Assoc, 9, pp.e013841~ (2020)
143. Havlik RJ, "Variability in midlife systolic blood pressure is related to latelife brain white matter lesions : the Honolulu-Asia aging study", Stroke, 33, pp.26~30 (2002)
144. Zhou TL, "Blood pressure variability and microvascular dysfunction : the Maastricht study", J Hypertens, 38, pp.1541~1550 (2020)
145. Jiang X, "Multiscale dynamics of blood pressure fluctuation is associated with white matter lesion burden in older adults with and without hypertension : observations from a pilot study", Front Cardiovasc Med, 8, pp.636702~ (2021)
146. Starmans NL, "Twenty-four hour blood pressure variability and the prevalence and the progression of cerebral white matter hyperintensities", J Cereb Blood Flow Metab, 43, pp.801~811 (2023)
147. Ma Y, "Blood pressure variability and cerebral small vessel disease : a systematic review and meta-analysis of population-based cohorts", Stroke, 51, pp.82~89 (2020)
148. Jeerakathil T, "Stroke risk profile predicts white matter hyperintensity volume : the Framingham study", Stroke, 35, pp.1857~1861 (2004)
149. Jongen C, "Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus", Diabetologia, 50, pp.1509~1516 (2007)
150. King KS, "Vascular risk profile and white matter hyperintensity volume among Mexican Americans and non-Hispanic Whites : the HABLE study", Alzheimers Dement(Amst), 14, pp.e12263~ (2022)
151. Guan J, "Analysis of risk factors in patients with leukoaraiosis", Medicine(Baltimore), 96, pp.e6153~ (2017)
152. Hilal S, "Prevalence, risk factors and consequences of cerebral small vessel diseases : data from three Asian countries", J Neurol Neurosurg Psychiatry, 88, pp.669~674 (2017)
153. Debette S, "Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline", Neurology, 77, pp.461~468 (2011)
154. Power MC, "Smoking and white matter hyperintensity progression : the ARIC-MRI study", Neurology, 84, pp.841~848 (2015)
155. Das AS, "Asymptomatic cerebral small vessel disease : insights from population-based studies", J Stroke, 21, pp.121~138 (2019)
156. Jimenez-Conde J, "Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke", Stroke, 41, pp.437~442 (2010)
157. Ohwaki K, "Hypercholesterolemia is associated with a lower risk of cerebral ischemic small vessel disease detected on brain checkups", Clin Neurol Neurosurg, 115, pp.669~672 (2013)
158. Ke D, "Hypertriglyceridemia is associated with reduced leukoaraiosis severity in patients with a small vessel stroke", Behav Neurol, 2018, pp.1361780~ (2018)
159. Wang Z, "Risk factors of cerebral small vessel disease : a systematic review and metaanalysis", Medicine(Baltimore), 100, pp.e28229~ (2021)
160. Okamura T, "Metabolically healthy obesity and risk of leukoaraiosis;a population based cross-sectional study", Endocr J, 65, pp.669~675 (2018)
161. Coutinho T, "Aortic pulse wave velocity is associated with measures of subclinical target organ damage", JACC Cardiovasc Imaging, 4, pp.754~761 (2011)
162. Mitchell GF, "Arterial stiffness, pressure and flow pulsatility and brain structure and function : the age, gene", environment susceptibility--Reykjavik study, 2011, pp.134(Pt 11), 3398~3407
163. Poels MM, "Arterial stiffness and cerebral small vessel disease : the Rotterdam scan study", Stroke, 43, pp.2637~2642 (2012)
164. Saji N, "Increased brachial-ankle pulse wave velocity is independently associated with white matter hyperintensities", Neuroepidemiology, 36, pp.252~257 (2011)
165. Tsao CW, "Relations of arterial stiffness and endothelial function to brain aging in the community", Neurology, 81, pp.984~991 (2013)
166. Singer J, "Arterial stiffness, the brain and cognition : a systematic review", Ageing Res Rev, 15, pp.16~27 (2014)
167. van Sloten TT, "Association between arterial stiffness, cerebral small vessel disease and cognitive impairment : a systematic review and meta-analysis", Neurosci Biobehav Rev, 53, pp.121~130 (2015)
168. Haidegger M, "Arterial stiffness and its influence on cerebral morphology and cognitive function", Ther Adv Neurol Disord, 16, pp.17562864231180715~ (2023)
169. Caughey MC, "Relationship between central artery stiffness, brain arterial dilation, and white matter hyperintensities in older adults : the ARIC study—brief report", Arterioscler Thromb Vasc Biol, 41, pp.2109~2116 (2021)
170. Robert C, "Effects of carotid artery stiffness on cerebral small-vessel disease and cognition", J Am Heart Assoc, 11, pp.e027295~ (2022)
171. Miyagi T, "Arterial stiffness is associated with small vessel disease irrespective of blood pressure in stroke-free individuals", Stroke, 54, pp.2814~2821 (2023)
172. Tomoto T, "Central arterial stiffness, brain white matter hyperintensity and total brain volume across the adult lifespan", J Hypertens, 41, pp.819~829 (2023)
173. Brandts A, "Association of aortic arch pulse wave velocity with left ventricular mass and lacunar brain infarcts in hypertensive patients : assessment with MR imaging", Radiology, 253, pp.681~688 (2009)
174. van Elderen SG, "Aortic stiffness is associated with cardiac function and cerebral small vessel disease in patients with type 1 diabetes mellitus : assessment by magnetic resonance imaging", Eur Radiol, 20, pp.1132~1138 (2010)
175. Ohmine T, "Association between arterial stiffness and cerebral white matter lesions in community-dwelling elderly subjects", Hypertens Res, 31, pp.75~81 (2008)
176. Hannawi Y, "Association of vascular properties with the brain white matter hyperintensity in middle-aged population", J Am Heart Assoc, 11, pp.e024606~ (2022)
177. Funck KL, "Arterial stiffness and progression of cerebral white matter hyperintensities in patients with type 2 diabetes and matched controls : a 5-year cohort study", Diabetol Metab Syndr, 13, pp.71~ (2021)
178. Del Brutto OH, "Arterial stiffness and progression of white matter hyperintensities of presumed vascular origin in communitydwelling older adults of Amerindian ancestry : the Atahualpa project cohort", Clin Neurol Neurosurg, 221, pp.107411~ (2022)
179. Allison EY, "Association of arterial stiffness index and brain structure in the UK Biobank : a 10-year retrospective analysis", Aging Dis (2023)[DOI]
180. Scheuermann BC, "Associations of cerebrovascular regulation and arterial stiffness with cerebral small vessel disease : a systematic review and meta-analysis", J Am Heart Assoc, 12, pp.e032616~ (2023)
181. Hassan A, "Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction", Brain, 127(Pt 1), pp.212~219 (2004)
182. Welch GN, "Homocysteine and atherothrombosis", N Engl J Med, 338, pp.1042~1050 (1998)
183. Kamath AF, "Elevated levels of homocysteine compromise blood-brain barrier integrity in mice", Blood, 107, pp.591~593 (2006)
184. Wald DS, "Homocysteine and cardiovascular disease : evidence on causality from a meta-analysis", BMJ, 325, pp.1202~ (2002)
185. Homocysteine Studies Collaboration, "Homocysteine and risk of ischemic heart disease and stroke : a meta-analysis", JAMA, 288, pp.2015~2022 (2002)
186. Boushey CJ, "A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes", JAMA, 274, pp.1049~1057 (1995)
187. Dufouil C, "Homocysteine, white matter hyperintensities, and cognition in healthy elderly people", Ann Neurol, 53, pp.214~221 (2003)
188. Longstreth WT Jr, "Plasma total homocysteine levels and cranial magnetic resonance imaging findings in elderly persons : the cardiovascular health study", Arch Neurol, 61, pp.67~72 (2004)
189. Seshadri S, "Association of plasma total homocysteine levels with subclinical brain injury : cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study", Arch Neurol, 65, pp.642~649 (2008)
190. Hogervorst E, "Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes(leukoaraiosis)in patients with Alzheimer disease", Arch Neurol, 59, pp.787~793 (2002)
191. Vermeer SE, "Homocysteine, silent brain infarcts, and white matter lesions : the Rotterdam scan study", Ann Neurol, 51, pp.285~289 (2002)
192. Wright CB, "Total homocysteine is associated with white matter hyperintensity volume : the northern Manhattan study", Stroke, 36, pp.1207~1211 (2005)
193. Naka H, "Plasma total homocysteine levels are associated with advanced leukoaraiosis but not with asymptomatic microbleeds on T2*-weighted MRI in patients with stroke", Eur J Neurol, 13, pp.261~265 (2006)
194. Shimomura T, "Hyperhomocysteinaemia is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients", Eur J Neurol, 15, pp.289~294 (2008)
195. Anan F, "The role of homocysteine as a significant risk factor for white matter lesions in Japanese women with rheumatoid arthritis", Metabolism, 58, pp.69~73 (2009)
196. Tseng YL, "Association of plasma homocysteine concentration with cerebral white matter hyperintensity on magnetic resonance images in stroke patients", J Neurol Sci, 284, pp.36~39 (2009)
197. Pavlovic AM, "Increased total homocysteine level is associated with clinical status and severity of white matter changes in symptomatic patients with subcortical small vessel disease", Clin Neurol Neurosurg, 113, pp.711~715 (2011)
198. Raz N, "Volume of white matter hyperintensities in healthy adults : contribution of age, vascular risk factors, and inflammation-related genetic variants", Biochim Biophys Acta, 1822, pp.361~369 (2012)
199. Cloonan L, "Metabolic determinants of white matter hyperintensity burden in patients with ischemic stroke", Atherosclerosis, 240, pp.149~153 (2015)
200. Shan Y, "Risk factors and clinical manifestations of juxtacortical small lesions : a neuroimaging study", Front Neurol, 8, pp.497~ (2017)
201. Piao X, "Association between homocysteine and cerebral small vessel disease : a meta-analysis", J Stroke Cerebrovasc Dis, 27, pp.2423~2430 (2018)
202. Shen Y, "Association of homocysteine, folate, and white matter hyperintensities in Parkinson’s patients with different motor phenotypes", Neurol Sci, 40, pp.1855~1863 (2019)
203. Nam KW, "Serum homocysteine level is related to cerebral small vessel disease in a healthy population", Neurology, 92, pp.e317~e325 (2019)
204. Wang X, "Association between homocysteine and white matter hyperintensities in rural-dwelling Chinese people with asymptomatic intracranial arterial stenosis : a population-based study", Brain Behav, 11, pp.e02205~ (2021)
205. Kloppenborg RP, "Homocysteine and progression of generalized small-vessel disease : the SMART-MR study", Neurology, 82, pp.777~783 (2014)
206. Hooshmand B, "Association of vitamin B12, folate, and sulfur amino acids with brain magnetic resonance imaging measures in older adults : a longitudinal population-based study", JAMA Psychiatry, 73, pp.606~613 (2016)
207. Sachdev P, "Homocysteine and the brain in midadult life : evidence for an increased risk of leukoaraiosis in men", Arch Neurol, 61, pp.1369~1376 (2004)
208. Gao Y, "Homocysteine level is associated with white matter hyperintensity locations in patients with acute ischemic stroke", PLoS One, 10, pp.e0144431~ (2015)
209. Lee KO, "Differential impact of plasma homocysteine levels on the periventricular and subcortical white matter hyperintensities on the brain", Front Neurol, 10, pp.1174~ (2019)
210. Refsum H, "Facts and recommendations about total homocysteine determinations : an expert opinion", Clin Chem, 50, pp.3~32 (2004)
211. Selhub J, "Vitamin status and intake as primary determinants of homocysteinemia in an elderly population", JAMA, 270, pp.2693~2698 (1993)
212. Clarke R, "Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease", Arch Neurol, 55, pp.1449~1455 (1998)
213. Stabler SP, "Vitamin B12 deficiency", N Engl J Med, 368, pp.149~160 (2013)
214. Selhub J, "B vitamins, homocysteine, and neurocognitive function in the elderly", Am J Clin Nutr, 71, pp.614S~620S (2000)
215. Kado DM, "Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults : MacArthur studies of successful aging", Am J Med, 118, pp.161~167 (2005)
216. Pieters B, "Periventricular white matter lucencies relate to low vitamin B12 levels in patients with small vessel stroke", Stroke, 40, pp.1623~1626 (2009)
217. de Lau LM, "Plasma vitamin B12 status and cerebral white-matter lesions", J Neurol Neurosurg Psychiatry, 80, pp.149~157 (2009)
218. van Overbeek EC, "Vitamin B12and progression of white matter lesions. A 2-year follow-up study in first-ever lacunar stroke patients", PLoS One, 8, pp.e78100~ (2013)
219. Iosifescu DV, "Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder(part I)", Psychiatry Res, 140, pp.291~299 (2005)
220. Scott TM, "Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders", Am J Geriatr Psychiatry, 12, pp.631~638 (2004)
221. Hickie I, "Vascular risk and low serum B12 predict white matter lesions in patients with major depression", J Affect Disord, 85, pp.327~332 (2005)
222. Tangney CC, "Vitamin B12, cognition, and brain MRI measures : a cross-sectional examination", Neurology, 77, pp.1276~1282 (2011)
223. Narayan SK, "Elevated plasma homocysteine is associated with increased brain atrophy rates in older subjects with mild hypertension", Dement Geriatr Cogn Disord, 31, pp.341~348 (2011)
224. Sponne IE, "Inhibition of vitamin B12 metabolism by OH-cobalamin c-lactam in rat oligodendrocytes in culture : a model for studying neuropathy due to vitamin B12 deficiency", Neurosci Lett, 288, pp.191~194 (2000)
225. Kim S, "Biological methylation of myelin basic protein : enzymology and biological significance", Int J Biochem Cell Biol, 29, pp.743~751 (1997)
226. Annweiler C, "Vitamin D and cognitive performance in adults : a systematic review", Eur J Neurol, 16, pp.1083~1089 (2009)
227. Sultan S, "Neuroimaging changes associated with vitamin D deficiency–a narrative review", Nutr Neurosci, 25, pp.1650~1658 (2022)
228. Zhao Y, "Impact of 25-hydroxy vitamin D on white matter hyperintensity in elderly patients : a systematic review and meta-analysis", Front Neurol, 12, pp.721427~ (2022)
229. Buell JS, "25-hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services", Neurology, 74, pp.18~26 (2010)
230. Prager JM, "Association of white matter hyperintensities with low serum 25-hydroxyvitamin D levels", AJNR Am J Neuroradiol, 35, pp.1145~1149 (2014)
231. Chung PW, "25-hydroxyvitamin D status is associated with chronic cerebral small vessel disease", Stroke, 46, pp.248~251 (2015)
232. Feng C, "25-Hydroxy vitamin D level is associated with total MRI burden of cerebral small vessel disease in ischemic stroke patients", Int J Neurosci, 129, pp.49~54 (2019)
233. Annweiler C, "Vitamin D and white matter abnormalities in older adults : a quantitative volumetric analysis of brain MRI", Exp Gerontol, 63, pp.41~47 (2015)
234. Wang L, "Association between serum 25-hydroxyvitamin D level and cognitive impairment in patients with white matter lesions : a cross-sectional study", Med Princ Pract, 29, pp.451~457 (2020)
235. Sakurai T, "Lower vitamin D is associated with white matter hyperintensity in elderly women with Alzheimer’s disease and amnestic mild cognitive impairment", J Am Geriatr Soc, 62, pp.1993~1994 (2014)
236. Schramm S, "Vitamin D and white matter hyperintensities : results of the population-based Heinz Nixdorf Recall Study and 1000BRAINS", Eur J Neurol, 28, pp.1849~1858 (2021)
237. Annweiler C, "Vitamin D and white matter abnormalities in older adults : a cross-sectional neuroimaging study", Eur J Neurol, 21, pp.1436~ (2014)
238. Michos ED, "Vitamin D and subclinical cerebrovascular disease : the atherosclerosis risk in communities brain magnetic resonance imaging study", JAMA Neurol, 71, pp.863~871 (2014)
239. Littlejohns TJ, "Vitamin D and risk of neuroimaging abnormalities", PLoS One, 11, pp.e0154896~ (2016)
240. Karakis I, "Association of serum vitamin D with the risk of incident dementia and subclinical indices of brain aging : the Framingham heart study", J Alzheimers Dis, 51, pp.451~461 (2016)
241. Bowman GL, "Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging", Neurology, 78, pp.241~249 (2012)
242. Brouwer-Brolsma EM, "Higher serum 25-hydroxyvitamin D and lower plasma glucose are associated with larger gray matter volume but not with white matter or total brain volume in Dutch communitydwelling older adults", J Nutr, 145, pp.1817~1823 (2015)
243. Putaala J, "Silent brain infarcts and leukoaraiosis in young adults with first-ever ischemic stroke", Neurology, 72, pp.1823~1829 (2009)
244. Kim KW, "Visceral obesity is associated with white matter hyperintensity and lacunar infarct", Int J Obes(Lond), 41, pp.683~688 (2017)
245. Lampe L, "Visceral obesity relates to deep white matter hyperintensities via inflammation", Ann Neurol, 85, pp.194~203 (2019)
246. Alqarni A, "Sex differences in risk factors for white matter hyperintensities in non-demented older individuals", Neurobiol Aging, 98, pp.197~204 (2021)
247. Seixas AA, "Obesity and race may explain differential burden of white matter hyperintensity load", Clin Interv Aging, 16, pp.1563~1571 (2021)
248. Murray AD, "Early life socioeconomic circumstance and late life brain hyperintensities--a population based cohort study", PLoS One, 9, pp.e88969~ (2014)
249. Mortamais M, "Education modulates the impact of white matter lesions on the risk of mild cognitive impairment and dementia", Am J Geriatr Psychiatry, 22, pp.1336~1345 (2014)
250. Schretlen DJ, "Serum uric acid and brain ischemia in normal elderly adults", Neurology, 69, pp.1418~1423 (2007)
251. Maniwa K, "Association between cystatin C gene polymorphism and the prevalence of white matter lesion in elderly healthy subjects", Sci Rep, 10, pp.4688~ (2020)
252. Backhouse EV, "Early life risk factors for cerebrovascular disease : a systematic review and meta-analysis", Neurology, 88, pp.976~984 (2017)
253. Christensen H, "Education, atrophy, and cognitive change in an epidemiological sample in early old age", Am J Geriatr Psychiatry, 17, pp.218~226 (2009)
254. Elkins JS, "Education and the cognitive decline associated with MRI-defined brain infarct", Neurology, 67, pp.435~440 (2006)
255. Breteler MM, "Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study : the Rotterdam study", Neurology, 44, pp.1246~1252 (1994)
256. Habes M, "White matter lesions : spatial heterogeneity, links to risk factors, cognition, genetics, and atrophy", Neurology, 91, pp.e964~e975 (2018)
257. Sachdev PS, "Sex differences in the causes and consequences of white matter hyperintensities", Neurobiol Aging, 30, pp.946~956 (2009)
258. Sullivan P, "Risk factors for white matter changes detected by magnetic resonance imaging in the elderly", Stroke, 21, pp.1424~1428 (1990)
259. Schmidt R, "Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers", Arch Neurol, 49, pp.825~827 (1992)
260. Assareh AA, "Renin-angiotensin system genetic polymorphisms and brain white matter lesions in older Australians", Am J Hypertens, 27, pp.1191~1198 (2014)
261. Geerlings MI, "Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease. The SMARTMR study", Atherosclerosis, 210, pp.130~136 (2010)
262. Brickman AM, "Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan", Arch Neurol, 65, pp.1053~1061 (2008)
263. Nyquist PA, "Extreme deep white matter hyperintensity volumes are associated with African American race", Cerebrovasc Dis, 37, pp.244~250 (2014)
264. Gottesman RF, "Blood pressure and white-matter disease progression in a biethnic cohort : atherosclerosis risk in communities(ARIC)study", Stroke, 41, pp.3~8 (2010)
265. Turner ST, "Heritability of leukoaraiosis in hypertensive sibships", Hypertension, 43, pp.483~487 (2004)
266. Atwood LD, "Genetic variation in white matter hyperintensity volume in the Framingham study", Stroke, 35, pp.1609~1613 (2004)
267. Sachdev PS, "White matter hyperintensities are under strong genetic influence", Stroke, 47, pp.1422~1428 (2016)
268. Paternoster L, "Genetic determinants of white matter hyperintensities on brain scans : a systematic assessment of 19 candidate gene polymorphisms in 46 studies in 19, 000 subjects", Stroke, 40, pp.2020~2026 (2009)
269. Lopez LM, "Genes from a translational analysis support a multifactorial nature of white matter hyperintensities", Stroke, 46, pp.341~347 (2015)
270. Jian X, "Exome chip analysis identifies low-frequency and rare variants in MRPL38 for white matter hyperintensities on brain magnetic resonance imaging", Stroke, 49, pp.1812~1819 (2018)
271. Yadav BK, "Single-nucleotide polymorphisms of tight junction component claudin-1 associated with leukoaraiosis", J Stroke Cerebrovasc Dis, 24, pp.1662~1670 (2015)
272. Oliveira-Filho J, "COX-2 rs20417 polymorphism is associated with stroke and white matter disease", J Stroke Cerebrovasc Dis, 24, pp.1817~1822 (2015)
273. Zhang M, "Correlation of matrix metalloproteinase-2 single nucleotide polymorphisms with the risk of small vessel disease(SVD)", J Neurol Sci, 356, pp.61~64 (2015)
274. Yadav BK, "Association of rs2075575and rs9951307 polymorphisms of AQP-4 gene with leukoaraiosis", J Stroke Cerebrovasc Dis, 23, pp.1199~1206 (2014)
275. Huang WQ, "Analysis of genetic polymorphisms associated with leukoaraiosis in the southern Chinese population: a case-control study", Medicine(Baltimore), 95, pp.e3857~ (2016)
276. Huang WQ, "The associations of PMF1, ICAM1, AGT, TRIM65, FBF1, and ACOX1variants with leukoaraiosis in Chinese population", Front Genet, 10, pp.615~ (2019)
277. Yadav BK, "Single-nucleotide polymorphisms of the adherent junction component cadherin gene are associated with leukoaraiosis", Gene, 676, pp.65~72 (2018)
278. Yadav BK, "Association of genetic variation in a Wnt signaling pathway gene(β-catenin)with susceptibility to leukoaraiosis", Genet Test Mol Biomarkers, 24, pp.708~716 (2020)
279. Li J, "Replication of top loci from COL4A1", 2 associated with white matter hyperintensity burden in patients with ischemic stroke, 2020, pp.51, 3751~3755
280. Parikh NS, "Association between PNPLA3 rs738409 G variant and MRI cerebrovascular disease biomarkers", J Neurol Sci, 416, pp.116981~ (2020)
281. Davis CM, "GPR39 localization in the aging human brain and correlation of expression and polymorphism with vascular cognitive impairment", Alzheimers Dement(N Y), 7, pp.e12214~ (2021)
282. Liu JY, "Rare NOTCH3 variants in a Chinese population-based cohort and its relationship with cerebral small vessel disease", Stroke, 52, pp.3918~3925 (2021)
283. Ferroni P, "Association of LTA and SOD gene polymorphisms with cerebral white matter hyperintensities in migraine patients", Int J Mol Sci, 23, pp.13781~ (2022)
284. Gao Y, "HLA-C*07 : 01and HLA-DQB1*02 : 01 protect against white matter hyperintensities and deterioration of cognitive function : a population-based cohort study", Brain Behav Immun, 115, pp.250~257 (2024)
285. Fornage M, "Genome-wide association studies of cerebral white matter lesion burden : the CHARGE consortium", Ann Neurol, 69, pp.928~939 (2011)
286. Verhaaren BF, "Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI", Circ Cardiovasc Genet, 8, pp.398~409 (2015)
287. Malik R, "Whole-exome sequencing reveals a role of HTRA1 and EGFL8 in brain white matter hyperintensities", Brain, 144, pp.2670~2682 (2021)
288. Traylor M, "Genetic variation in PLEKHG1 is associated with white matter hyperintensities(n = 11, 226)", Neurology, 92, pp.e749~e757 (2019)
289. Persyn E, "Genome-wide association study of MRI markers of cerebral small vessel disease in 42, 310 participants", Nat Commun, 11, pp.2175~ (2020)
290. Rutten-Jacobs LCA, "Genetic study of white matter integrity in UK Biobank(n=8448)and the overlap with stroke, depression, and dementia", Stroke, 49, pp.1340~1347 (2018)
291. Armstrong NJ, "Common genetic variation indicates separate causes for periventricular and deep white matter hyperintensities", Stroke, 51, pp.2111~2121 (2020)
292. Simpson JE, "Microarray RNA expression analysis of cerebral white matter lesions reveals changes in multiple functional pathways", Stroke, 40, pp.369~375 (2009)
293. Xu H, "Distinctive RNA expression profiles in blood associated with white matter hyperintensities in brain", Stroke, 41, pp.2744~2749 (2010)
294. Lin H, "Whole blood gene expression and white matter hyperintensities", Mol Neurodegener, 12, pp.67~ (2017)
295. Jickling GC, "Progression of cerebral white matter hyperintensities is related to leucocyte gene expression", Brain, 145, pp.3179~3186 (2022)
296. Hou XH, "Genomewide association study identifies Alzheimer’s risk variant in MS4A6A influencing cerebrospinal fluid sTREM2 levels", Neurobiol Aging, 84, pp.241~ (2019)
297. Peters XQ, "Zoning in on Tankyrases : a brief review on the past, present and prospective studies", Anticancer Agents Med Chem, 19, pp.1920~1934 (2019)
298. Yang HY, "Tankyrase promotes aerobic glycolysis and proliferation of ovarian cancer through activation of Wnt", β-catenin signaling, 2019, pp.2019, 2686340~
299. Iwaya T, "Infrequent mutation of the human envoplakin gene is closely linked to the tylosis oesophageal cancer locus in sporadic oesophageal squamous cell carcinomas", Oncol Rep, 13, pp.703~707 (2005)
300. Weber R, "Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes(PRoFESS)MRI substudy", Stroke, 43, pp.2336~2342 (2012)
301. Peng J, "Excessive lowering of blood pressure is not beneficial for progression of brain white matter hyperintensive and cognitive impairment in elderly hypertensive patients : 4-year follow-up study", J Am Med Dir Assoc, 15, pp.904~910 (2014)
302. Murray AM, "ACCORDION MIND : results of the observational extension of the ACCORD MIND randomised trial", Diabetologia, 60, pp.69~80 (2017)
303. Godin O, "Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes : the three-city(3C)-Dijon magnetic resonance imaging study", Circulation, 123, pp.266~273 (2011)
304. Schiffrin EL, "Blood pressure lowering in PROGRESS(perindopril protection against recurrent stroke study)and white matter hyperintensities : should this progress matter to patients?", Circulation, 112, pp.1525~1526 (2005)
305. van Dalen JW, "Effect of long-term vascular care on progression of cerebrovascular lesions : magnetic resonance imaging substudy of the PreDIVA trial(prevention of dementia by intensive vascular care)", Stroke, 48, pp.1842~1848 (2017)
306. de Havenon A, "Blood pressure, glycemic control, and white matter hyperintensity progression in type 2 diabetics", Neurology, 92, pp.e1168~e1175 (2019)
307. White WB, "Effects of intensive versus standard ambulatory blood pressure control on cerebrovascular outcomes in older people(INFINITY)", Circulation, 140, pp.1626~1635 (2019)
308. Lai Y, "Effect of intensive blood pressure control on the prevention of white matter hyperintensity : systematic review and meta-analysis of randomized trials", J Clin Hypertens(Greenwich), 22, pp.1968~1973 (2020)
309. Su C, "The relation between antihypertensive treatment and progression of cerebral small vessel disease : a systematic review and meta-analysis of randomized controlled trials", Medicine(Baltimore), 100, pp.e26749~ (2021)
310. Heutz RA, "Antihypertensives in dementia : good or bad for the brain?", J Cereb Blood Flow Metab, 43, pp.1796~1799 (2023)
311. Willmot M, "Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke", Hypertension, 47, pp.1209~1215 (2006)
312. Sare GM, "Effect of antihypertensive agents on cerebral blood flow and flow velocity in acute ischaemic stroke : systematic review of controlled studies", J Hypertens, 26, pp.1058~1064 (2008)
313. Kate M, "Blood pressure reduction in hypertensive acute ischemic stroke patients does not affect cerebral blood flow", J Cereb Blood Flow Metab, 39, pp.1878~1887 (2019)
314. Croall ID, "Effect of standard vs intensive blood pressure control on cerebral blood flow in small vessel disease : the PRESERVE randomized clinical trial", JAMA Neurol, 75, pp.720~727 (2018)
315. de Heus RAA, "Longitudinal changes in the control mechanisms for blood pressure and cerebral blood flow in Alzheimer’s disease : secondary results of a randomized controlled trial", Cereb Circ Cogn Behav, 2, pp.100024~ (2021)
316. van Rijssel AE, "Effect of antihypertensive treatment on cerebral blood flow in older adults : a systematic review and meta-analysis", Hypertension, 79, pp.1067~1078 (2022)
317. Efimova NY, "Influence of antihypertensive therapy on cerebral perfusion in patients with metabolic syndrome : relationship with cognitive function and 24-h arterial blood pressure monitoring", Cardiovasc Ther, 33, pp.209~215 (2015)
318. Dolui S, "Association of intensive vs standard blood pressure control with cerebral blood flow : secondary analysis of the SPRINT MIND randomized clinical trial", JAMA Neurol, 79, pp.380~389 (2022)
319. Ikeme JC, "Cerebral white matter hyperintensities, kidney function decline, and recurrent stroke after intensive blood pressure lowering : results from the secondary prevention of small subcortical strokes(SPS3)trial", J Am Heart Assoc, 8, pp.e010091~ (2019)
320. Williamson JD, "Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels : a randomized clinical trial", JAMA Intern Med, 174, pp.324~333 (2014)
321. Verghese J, "Low blood pressure and the risk of dementia in very old individuals", Neurology, 61, pp.1667~1672 (2003)
322. McGrath ER, "Blood pressure from mid-to late life and risk of incident dementia", Neurology, 89, pp.2447~2454 (2017)
323. Yeung A, "Intensive control of hypertension and risk of Alzheimer’s dementia in older adults with depression", Int J Geriatr Psychiatry, 35, pp.888~896 (2020)
324. Jiang C, "Effects of intensive blood pressure control on cardiovascular and cognitive outcomes in patients with atrial fibrillation : insights from the SPRINT trial", Europace, 24, pp.1560~1568 (2022)
325. Poon IO, "Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment", Pharmacotherapy, 28, pp.366~375 (2008)
326. Hughes D, "Association of blood pressure lowering with incident dementia or cognitive impairment : a systematic review and meta-analysis", JAMA, 323, pp.1934~1944 (2020)
327. Peters R, "Blood pressure lowering and prevention of dementia : an individual patient data meta-analysis", Eur Heart J, 43, pp.4980~4990 (2022)
328. Ding J, "Antihypertensive medications and risk for incident dementia and Alzheimer’s disease : a meta-analysis of individual participant data from prospective cohort studies", Lancet Neurol, 19, pp.61~70 (2020)
329. Lee CJ, "Protective effect of controlled blood pressure on risk of dementia in low-risk, grade 1 hypertension", J Hypertens, 39, pp.1662~1669 (2021)
330. Canavan M, "Hypertension and cognitive impairment : a review of mechanisms and key concepts", Front Neurol, 13, pp.821135~ (2022)
331. Tully PJ, "Dementia risk with antihypertensive use and blood pressure variability : a cohort study", Neurology, 87, pp.601~608 (2016)
332. Lennon MJ, "Use of antihypertensives, blood pressure, and estimated risk of dementia in late life : an individual participant data meta-analysis", JAMA Netw Open, 6, pp.e2333353~ (2023)
333. Jiang C, "Diastolic blood pressure and intensive blood pressure control on cognitive outcomes : insights from the SPRINT MIND trial", Hypertension, 80, pp.580~589 (2023)
334. Peters R, "Incident dementia and blood pressure lowering in the hypertension in the very elderly trial cognitive function assessment(HYVET-COG) : a double-blind, placebo controlled trial", Lancet Neurol, 7, pp.683~689 (2008)
335. van Middelaar T, "Blood pressurelowering interventions to prevent dementia : a systematic review and meta-analysis", J Hypertens, 36, pp.1780~1787 (2018)
336. SPRINT MIND Investigators for the SPRINT Research Group, "Effect of intensive vs standard blood pressure control on probable dementia : a randomized clinical trial", JAMA, 321, pp.553~561 (2019)
337. Rojas-Saunero LP, "Hypothetical blood-pressure-lowering interventions and risk of stroke and dementia", Eur J Epidemiol, 36, pp.69~79 (2021)
338. Kellar D, "Intranasal insulin reduces white matter hyperintensity progression in association with improvements in cognition and CSF biomarker profiles in mild cognitive impairment and Alzheimer’s disease", J Prev Alzheimers Dis, 8, pp.240~248 (2021)
339. Inkeri J, "Glycemic control is not related to cerebral small vessel disease in neurologically asymptomatic individuals with type 1 diabetes", Acta Diabetol, 59, pp.481~490 (2022)
340. Livny A, "Long-term variability in glycemic control is associated with white matter hyperintensities in APOE4 genotype carriers with type 2 diabetes", Diabetes Care, 39, pp.1056~1059 (2016)
341. Launer LJ, "Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes(ACCORD MIND) : a randomised open-label substudy", Lancet Neurol, 10, pp.969~977 (2011)
342. Wardlaw JM, "ESO guideline on covert cerebral small vessel disease", Eur Stroke J, pp.CXI~CLXII (2021)
343. Mortensen MB, "Primary prevention with statins in the elderly", J Am Coll Cardiol, 71, pp.85~94 (2018)
344. Cholesterol Treatment Trialists’ Collaboration, "Efficacy and safety of statin therapy in older people : a meta-analysis of individual participant data from 28 randomised controlled trials", Lancet, 393, pp.407~415 (2019)
345. Martínez-Sánchez P, "The beneficial effect of statins treatment by stroke subtype", Eur J Neurol, 16, pp.127~133 (2009)
346. Bernick C, "Statins and cognitive function in the elderly : the cardiovascular health study", Neurology, 65, pp.1388~1394 (2005)
347. ten Dam VH, "Effect of pravastatin on cerebral infarcts and white matter lesions", Neurology, 64, pp.1807~1809 (2005)
348. Ramanan VK, "Statins and brain health : Alzheimer’s disease and cerebrovascular disease biomarkers in older adults", J Alzheimers Dis, 65, pp.1345~1352 (2018)
349. Vogt NM, "Effects of simvastatin on white matter integrity in healthy middle-aged adults", Ann Clin Transl Neurol, 8, pp.1656~1667 (2021)
350. Mok VC, "Effects of statins on the progression of cerebral white matter lesion : post hoc analysis of the ROCAS(regression of cerebral artery stenosis)study", J Neurol, 256, pp.750~757 (2009)
351. Ji T, "Effect of low-dose statins and apolipoprotein E genotype on cerebral small vessel disease in older hypertensive patients : a subgroup analysis of a randomized clinical trial", J Am Med Dir Assoc, 19, pp.995~1002 (2018)
352. Zhang H, "Effects of sartans and low-dose statins on cerebral white matter hyperintensities and cognitive function in older patients with hypertension : a randomized, double-blind and placebocontrolled clinical trial", Hypertens Res, 42, pp.717~729 (2019)
353. Guo Y, "Assessing the effectiveness of statin therapy for alleviating cerebral small vessel disease progression in people ≥75 years of age", BMC Geriatr, 20, pp.292~ (2020)
354. Xue J, "High-dose atorvastatin improves vascular endothelial function in patients with leukoaraiosis", J Clin Lab Anal, 34, pp.e23081~ (2020)
355. Sterzer P, "Pravastatin improves cerebral vasomotor reactivity in patients with subcortical small-vessel disease", Stroke, 32, pp.2817~2820 (2001)
356. Ii M, "Statins and the endothelium", Vascul Pharmacol, 46, pp.1~9 (2007)
357. Liu Z, "Treatment with telmisartan", rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17, Atherosclerosis, pp.2014, 233[DOI]
358. Janic´ M, "A low-dose combination of fluvastatin and valsartan : a new"drug"and a new approach for decreasing the arterial age", Biomed Res Int, 2015, pp.235709~ (2015)
359. Rizos CV, "The effect of combining rosuvastatin with sartans of different peroxisome proliferator receptor-γ activating capacity on plasma 8-isoprostane prostaglandin F2a levels", Arch Med Sci, 9, pp.172~176 (2013)
360. Kim JS, "Role of blood lipid levels and lipid-lowering therapy in stroke patients with different levels of cerebral artery diseases : reconsidering recent stroke guidelines", J Stroke, 23, pp.149~161 (2021)
361. Collins R, "Effects of cholesterollowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions", Lancet, 363, pp.757~767 (2004)
362. Goldstein LB, "Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study", Neurology, 70(24 Pt 2), pp.2364~2370 (2008)
363. Hosomi N, "The Japan statin treatment against recurrent stroke(JSTARS) : a multicenter, randomized, open-label, parallel-group study", EBioMedicine, 2, pp.1071~1078 (2015)
364. Hosomi N, "Different influences of statin treatment in preventing at-risk stroke subtypes : a post hoc analysis of J-STARS", J Atheroscler Thromb, 27, pp.449~460 (2020)
365. Boxer AL, "Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment", Neurology, 64, pp.1431~1434 (2005)
366. Cavalieri M, "B vitamins and magnetic resonance imaging-detected ischemic brain lesions in patients with recent transient ischemic attack or stroke : the VITAmins TO Prevent Stroke(VITATOPS)MRI-substudy", Stroke, 43, pp.3266~3270 (2012)
367. Fassbender K, "Homocysteine in cerebral macroangiography and microangiopathy", Lancet, 353, pp.1586~1587 (1999)
368. Weir DG, "Brain function in the elderly : role of vitamin B12 and folate", Br Med Bull, 55, pp.669~682 (1999)
369. Park HK, "2022 Update of the Korean clinical practice guidelines for stroke : antithrombotic therapy for patients with acute ischemic stroke or transient ischemic attack", J Stroke, 24, pp.166~175 (2022)
370. Ishida K, "Antiplatelet strategies for secondary prevention of stroke and TIA", Curr Atheroscler Rep, 16, pp.449~ (2014)
371. Ter Telgte A, "Cerebral small vessel disease : from a focal to a global perspective", Nat Rev Neurol, 14, pp.387~398 (2018)
372. Huang N, "Aspirin promotes oligodendroglial differentiation through inhibition of Wnt signaling pathway", Mol Neurobiol, 53, pp.3258~3266 (2016)
373. Chen J, "Aspirin promotes oligodendrocyte precursor cell proliferation and differentiation after white matter lesion", Front Aging Neurosci, 6, pp.7~ (2014)
374. Holcombe A, "Chronic use of aspirin and total white matter lesion volume : results from the women’s health initiative memory study of magnetic resonance imaging study", J Stroke Cerebrovasc Dis, 26, pp.2128~2136 (2017)
375. Ward SA, "ASPREE-NEURO study protocol : a randomized controlled trial to determine the effect of low-dose aspirin on cerebral microbleeds, white matter hyperintensities, cognition, and stroke in the healthy elderly", Int J Stroke, 12, pp.108~113 (2017)
376. Zheng SL, "Association of aspirin use for primary prevention with cardiovascular events and bleeding events : a systematic review and meta-analysis", JAMA, 321, pp.277~287 (2019)
377. Shinohara Y, "Cilostazol for prevention of secondary stroke(CSPS 2) : an aspirin-controlled, double-blind, randomised noninferiority trial", Lancet Neurol, 9, pp.959~968 (2010)
378. Lin MP, "Cilostazol versus aspirin for secondary stroke prevention : systematic review and meta-analysis", J Stroke Cerebrovasc Dis, 30, pp.105581~ (2021)
379. Han HJ, "A comparison study of cilostazol and aspirin on changes in volume of cerebral small vessel disease white matter changes : protocol of a multicenter, randomized controlled trial", Dement Neurocogn Disord, 18, pp.138~148 (2019)
380. Kim BC, "Cilostazol versus aspirin on white matter changes in cerebral small vessel disease : a randomized controlled trial", Stroke, 53, pp.698~709 (2022)
381. Ip BYM, "Efficacy and safety of cilostazol in decreasing progression of cerebral white matter hyperintensities—a randomized controlled trial", Alzheimers Dement(N Y), 8, pp.e12369~ (2022)
382. Gons RA, "Cigarette smoking is associated with reduced microstructural integrity of cerebral white matter", Brain, 134(Pt 7), pp.2116~2124 (2011)
383. Akbar Z, "Associations of the MIND diet with cardiometabolic diseases and their risk factors : a systematic review", Diabetes Metab Syndr Obes, 16, pp.3353~3371 (2023)
384. Makin SDJ, "Small vessel disease and dietary salt intake : crosssectional study and systematic review", J Stroke Cerebrovasc Dis, 26, pp.3020~3028 (2017)
385. Strazzullo P, "Salt intake, stroke, and cardiovascular disease : meta-analysis of prospective studies", BMJ, 339, pp.b4567~ (2009)
386. Del Brutto OH, "Dietary oily fish intake is inversely associated with severity of white matter hyperintensities of presumed vascular origin. A population-based study in frequent fish consumers of Amerindian ancestry", J Stroke Cerebrovasc Dis, 30, pp.105778~ (2021)
387. Song S, "Mediterranean diet and white matter hyperintensity change over time in cognitively intact adults", Nutrients, 14, pp.3664~ (2022)
388. Barnes LL, "Trial of the MIND diet for prevention of cognitive decline in older persons", N Engl J Med, 389, pp.602~611 (2023)
389. Venkatraman VK, "Effect of a 24-month physical activity program on brain changes in older adults at risk of Alzheimer’s disease : the AIBL active trial", Neurobiol Aging, 89, pp.132~141 (2020)
390. Ho AJ, "The effects of physical activity, education, and body mass index on the aging brain", Hum Brain Mapp, 32, pp.1371~1382 (2011)
391. Rosano C, "Psychomotor speed and functional brain MRI 2 years after completing a physical activity treatment", J Gerontol A Biol Sci Med Sci, 65, pp.639~647 (2010)
392. Willey JZ, "Lower prevalence of silent brain infarcts in the physically active : the northern Manhattan study", Neurology, 76, pp.2112~2118 (2011)
393. Smith JA, "Complexity in the genetic architecture of leukoaraiosis in hypertensive sibships from the GENOA study", BMC Med Genomics, 2, pp.16~ (2009)
394. Sen A, "Association of cardiorespiratory fitness and morphological brain changes in the elderly : results of the Austrian stroke prevention study", Neurodegener Dis, 10, pp.135~137 (2012)
395. Tseng BY, "White matter integrity in physically fit older adults", Neuroimage, 82, pp.510~516 (2013)
396. Gow AJ, "Neuroprotective lifestyles and the aging brain : activity, atrophy, and white matter integrity", Neurology, 79, pp.1802~1808 (2012)
397. Torres ER, "Physical activity and white matter hyperintensities : a systematic review of quantitative studies", Prev Med Rep, 2, pp.319~325 (2015)
398. Podewils LJ, "Physical activity and white matter lesion progression : assessment using MRI", Neurology, 68, pp.1223~1226 (2007)
399. Pan Y, "Adherence to a healthy lifestyle and brain structural imaging markers", Eur J Epidemiol, 38, pp.657~668 (2023)

관련 논문AI추천